COVID-19 in Pediatric Survivors of Childhood Cancer and Hematopoietic
Cell Transplantation from A Single-Center in New York City
Abstract
Childhood cancer survivors are at increased risk for treatment-related
late effects; data are lacking on how COVID-19 infection impacts this
cohort. We assessed COVID-19-related symptoms; SARS-CoV-2 IgG
seroprevalence; and rate of COVID-19-related hospitalization among 321
asymptomatic survivors of childhood cancer or transplantation seen for
routine long-term follow-up between May-September 2020 in a New York
City tertiary cancer center. While 11% (n=35) reported possible
COVID-19-related symptoms, 7.8% (n=20) of those tested had positive
SARS-CoV-2 IgG, and only 1 patient (0.3%) required COVID-19 related
hospitalization. This report suggests that childhood cancer survivors
are at low risk for COVID-19 complications.